×

Estradiol derivative and estratopone containing sustained release intraocular implants and related methods

  • US 20050244471A1
  • Filed: 04/30/2004
  • Published: 11/03/2005
  • Est. Priority Date: 04/30/2004
  • Status: Abandoned Application
First Claim
Patent Images

1. A biodegradable intraocular implant comprising:

  • an estradiol derivative and a biodegradable polymer matrix that is substantially free of a polyvinyl alcohol and that releases drug at a rate effective to sustain release of an amount of the estradiol derivative from the implant for at least about one week after the implant is placed in an eye.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×